We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

RGR:NYSESturm, Ruger & Company, Inc. Analysis

Data as of 2026-04-28 - not real-time

$43.00

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

RGR is currently priced near the upper end of its short‑term trend, sitting above both its 20‑day and 50‑day moving averages. The momentum indicator RSI is in the high range, indicating strong buying pressure but also edging toward overbought territory. The MACD line sits just above its signal line, delivering a bullish signal, yet the histogram is nearly flat, suggesting waning momentum. Trading volume has been on a downtrend, which could limit price resilience on short‑term moves. The stock’s beta hovers close to market level, implying that broader market swings will be reflected in RGR’s price. Volatility is elevated, marking the stock as relatively volatile for its sector.
DCF valuation places fair value below the current market price, while the forward price‑to‑earnings multiple is comfortably under the industry average, creating a mixed picture. The dividend yield sits just above one percent, but the payout ratio is far above sustainable levels, raising doubts about its durability. Recent headlines highlight board tension, including criticism from a major shareholder and concerns that the board is focused on self‑preservation rather than shareholder value. An upcoming earnings release this week adds a near‑term catalyst that could swing sentiment sharply. Overall, the company carries a strong cash position, minimal debt, and exposure to a niche firearms market that remains subject to heightened regulatory scrutiny. These factors combine to suggest a cautious but potentially rewarding investment thesis for investors willing to navigate short‑term volatility.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Upcoming earnings release could trigger volatility
  • Technical momentum is strong but showing signs of fatigue
  • Decreasing volume limits short‑term price support

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Forward P/E advantage versus industry peers
  • Strong cash balance and low debt provide flexibility
  • Board controversy may weigh on investor confidence

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Undervalued relative to discounted cash‑flow estimate
  • Potential for margin improvement as cost structure stabilizes
  • Long‑term demand for firearms and defense products despite regulatory headwinds

Key Metrics & Analysis

Financial Health

Revenue Growth3.60%
Profit Margin-0.80%
P/E Ratio22.4
ROE-1.46%
ROA-1.95%
Debt/Equity0.64
P/B Ratio2.4
Op. Cash Flow$54.3M
Free Cash Flow$32.6M
Industry P/E31.1

Technical Analysis

TrendBullish
RSI67.0
Support$38.60
Resistance$43.43
MA 20$41.56
MA 50$39.80
MA 200$37.47
MACDBullish
VolumeDecreasing
Fear & Greed Index89.25

Valuation

Fair Value$37.96
Target Price$45.50
Upside/Downside5.81%
GradeFair
TypeBlend
Dividend Yield1.07%

Risk Assessment

Beta0.93
Volatility29.91%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.